But let me be direct about something most articles gloss over: these medications work by reducing your appetite so you eat less
Most evidence comes from post-hoc analyses, patient surveys, and real-world observations rather than randomized controlled trials designed to evaluate psychiatric outcomes
A recent Wall Street Journal article explores how recreational athletes, including runners, cyclists, and triathletes, are increasingly using GLP-1 medications to enhance performance by reducing body weight, improving endurance, and accelerating recovery
Novo Nordisk has highlighted strong early uptake for its obesity pill in the US in early 2026 , framing oral semaglutide in obesity as part of its growth strategy beyond injectables
Your job is to push that timeline as far out as possible through meticulous storage and handling